EMEA-002418-PIP01-18-M02

Key facts

Invented name
Supemtek
Active substance
  • Recombinant Influenza Hemagglutinin-strain A (H1N1 subtype)
  • Recombinant Influenza Hemagglutinin-strain A (H3N2 subtype)
  • Recombinant Influenza Hemagglutinin-strain B (Victoria lineage)
  • Recombinant Influenza Hemagglutinin-strain B (Yamagata lineage) (RIV4)
Therapeutic area
Vaccines
Decision number
P/0100/2022
PIP number
EMEA-002418-PIP01-18-M02
Pharmaceutical form(s)
Solution for injection in pre-filled syringe
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
Sanofi Pasteur

E-mail: contact-us@sanofi.com
Tel. +33 1 6974 5695

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating